Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies.

Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2794-802. doi: 10.1161/ATVBAHA.112.248039. Epub 2012 Aug 30.

2.

25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis.

Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M.

Ann Neurol. 2013 Jan;73(1):38-47. doi: 10.1002/ana.23738. Epub 2012 Dec 7.

PMID:
23225498
3.

25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants.

Brøndum-Jacobsen P, Benn M, Tybjaerg-Hansen A, Nordestgaard BG.

J Thromb Haemost. 2013 Mar;11(3):423-31. doi: 10.1111/jth.12118.

4.

Short telomere length, myocardial infarction, ischemic heart disease, and early death.

Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjærg-Hansen A, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):822-9. doi: 10.1161/ATVBAHA.111.237271. Epub 2011 Dec 22.

5.

Creatinine, eGFR and association with myocardial infarction, ischemic heart disease and early death in the general population.

Sibilitz KL, Benn M, Nordestgaard BG.

Atherosclerosis. 2014 Nov;237(1):67-75. doi: 10.1016/j.atherosclerosis.2014.08.040. Epub 2014 Sep 3.

PMID:
25222342
6.

Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease.

Grandi NC, Breitling LP, Vossen CY, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H.

Am Heart J. 2010 Jun;159(6):1044-51. doi: 10.1016/j.ahj.2010.03.031.

PMID:
20569718
7.

Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia.

Afzal S, Bojesen SE, Nordestgaard BG.

Alzheimers Dement. 2014 May;10(3):296-302. doi: 10.1016/j.jalz.2013.05.1765. Epub 2013 Jul 18.

PMID:
23871764
8.

Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland.

Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP.

Eur J Nutr. 2011 Aug;50(5):305-12. doi: 10.1007/s00394-010-0138-3. Epub 2010 Oct 26.

PMID:
20976461
9.

No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.

Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG.

Int J Epidemiol. 2015 Apr;44(2):651-61. doi: 10.1093/ije/dyv078. Epub 2015 May 16.

PMID:
25981321
10.

Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.

Eldrup N, Kragelund C, Steffensen R, Nordestgaard BG.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):677-83. doi: 10.1016/j.numecd.2010.11.003. Epub 2010 Dec 30.

PMID:
21194909
11.

Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women.

Benn M, Voss SS, Holmegard HN, Jensen GB, Tybjærg-Hansen A, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):471-7. doi: 10.1161/ATVBAHA.114.304821. Epub 2014 Dec 30.

12.

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.

Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):661-70. Epub 2006 Dec 14.

13.

Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis.

Afzal S, Bojesen SE, Nordestgaard BG.

Clin Chem. 2013 Feb;59(2):381-91. doi: 10.1373/clinchem.2012.193003. Epub 2012 Dec 11.

14.

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A.

JAMA. 2007 Jul 18;298(3):299-308.

PMID:
17635890
15.

Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.

Brodin E, Lerstad G, Grimnes G, Brækkan SK, Vik A, Brox J, Svartberg J, Jorde R, Hansen JB.

Thromb Haemost. 2013 May;109(5):885-90. doi: 10.1160/TH12-10-0728. Epub 2013 Feb 28.

PMID:
23446951
16.
17.

Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer.

Afzal S, Bojesen SE, Nordestgaard BG.

Clin Chem. 2013 May;59(5):771-80. doi: 10.1373/clinchem.2012.201939. Epub 2013 Mar 15.

18.

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.

Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG.

J Intern Med. 2011 Jul;270(1):65-75. doi: 10.1111/j.1365-2796.2010.02333.x. Epub 2010 Dec 27.

19.

Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.

Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H.

Eur J Epidemiol. 2013 Mar;28(3):267-75. doi: 10.1007/s10654-013-9769-z. Epub 2013 Jan 26.

PMID:
23354985
20.

A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.

Durup D, Jørgensen HL, Christensen J, Tjønneland A, Olsen A, Halkjær J, Lind B, Heegaard AM, Schwarz P.

J Clin Endocrinol Metab. 2015 Jun;100(6):2339-46. doi: 10.1210/jc.2014-4551. Epub 2015 Feb 24.

Supplemental Content

Support Center